Prospective cohort study in older patients reveals higher Cu/Zn ratio increases mortality risk, suggesting prognostic implications.
Among older adults in the ED, a higher serum Cu/Zn ratio was independently associated with increased 3-month mortality, highlighting its potential role as a prognostic biomarker. Further studies are warranted to investigate potential therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: